Skip to content

The effect of combination treatment with acupuncture and dapoxetine on lifelong premature ejaculation: a randomized controlled trial

The effect of combination treatment with acupuncture and dapoxetine on lifelong premature ejaculation: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066928
Enrollment
Unknown
Registered
2022-12-21
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature ejaculation

Interventions

Experimental group:Acupuncture and dapoxetine

Sponsors

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.The subject who meet ISSM diagnostic criteria for lifelong premature ejaculation and PEDT score=9 2.male, aged 18-60 3.The subject has a fixed stable adult female sexual partner and has regular sexual life 4.The subject agrees not to use any other drugs or devices which may affect IELT, including 5-ht inhibitors, Chinese herbal medicine (including decoction, Chinese patent medicine), compound lidocaine hydrochloride Gel, and special thickening condom during the study period 5.The subject (including partners) guarantees that they have no birth plan and voluntarily take appropriate contraceptive measures between the study period and 3 months after the last administration 6.The subject voluntarily signed the informed consent form

Exclusion criteria

Exclusion criteria: 1.A history of psychological diseases 2.Patients with cardiovascular disease, liver dysfunction, kidney dysfunction, diabetes 3.Patients with other sexual dysfunction 4.Patients with urinary and reproductive tract infections, congenital abnormal development of the reproductive system 5.Drugs, alcohol or substance abuse

Design outcomes

Primary

MeasureTime frame
intravaginal ejaculatory latency time;the premature ejaculation profile;

Secondary

MeasureTime frame
Discontinuation reasons;

Countries

China

Contacts

Public ContactCheng Yi

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

drycheng@163.com+86 18655195696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026